ID   XB-2
AC   CVCL_3624
SY   XB2; XB
DR   CLO; CLO_0009644
DR   ATCC; CL-177
DR   BCRC; 60546
DR   IZSLER; BS CL 128
DR   Wikidata; Q54994657
RX   Patent=US4016036;
RX   PubMed=730781;
RX   PubMed=1052770;
RX   PubMed=1690090;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-177.
CC   Breed/subspecies: CXBGB/By.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
RX   Patent=US4016036;
RA   Green H., Rheinwald J.G.;
RT   "Process for serially culturing keratinocytes.";
RL   Patent number US4016036, 05-Apr-1977.
//
RX   PubMed=730781; DOI=10.1002/jcp.1040970322;
RA   Morrissey J.H., Green H.;
RT   "Differentiation-related death of an established keratinocyte line in
RT   suspension culture.";
RL   J. Cell. Physiol. 97:469-476(1978).
//
RX   PubMed=1052770; DOI=10.1016/0092-8674(75)90183-X;
RA   Rheinwald J.G., Green H.;
RT   "Formation of a keratinizing epithelium in culture by a cloned cell
RT   line derived from a teratoma.";
RL   Cell 6:317-330(1975).
//
RX   PubMed=1690090; DOI=10.1093/carcin/11.3.371;
RA   Hewitt S.D., Duffy P.A., Orton T.C., Garner R.C.;
RT   "Effect of tumour promoters and non-genotoxic carcinogens on terminal
RT   differentiation and proliferation in mouse teratoma XB2 cells cultured
RT   in low calcium medium.";
RL   Carcinogenesis 11:371-375(1990).
//